A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.

The aim of this study was to determine whether educational length affects prostate-specific antigen (PSA) testing and the time to prostate biopsy for men with raised PSA values.

Using register data on all men in Stockholm County in 2013 (n = 1,052,841), the limited-duration point prevalence of PSA testing and time between test and prostate biopsy or repeat testing were analysed.

Patterns of follow-up were assessed using Kaplan-Meier product limit estimators and Cox proportional hazard models. Educational length was categorized as short (≤9 years), intermediate (10-12 years) or long (≥13 years).

PSA testing increased with educational length in all age groups. Among men aged 50-69 years, 61% with long and 54% with short education had had a PSA test within the preceding 10 years (p < 0. 001). In men with PSA 4-10 ng/ml, 40% [95% confidence interval (CI) 38-41] with long and 27% (95% CI 26-29) with short education underwent a prostate biopsy within 12 months. After adjusting for PSA level and age, educational length was still associated with the chance of having a prostate biopsy in men with PSA 4-10 ng/ml (hazard ratio 1. 22, 95% CI 1. 12-1. 31), but not in men with higher PSA values.

PSA testing increased with educational length. Men with long education were more likely to have a prostate biopsy after an increased PSA value below 10 ng/ml than men with short education. These differences may contribute to the worse prostate cancer outcomes observed among men with lower socioeconomic status.

Scandinavian journal of urology. 2015 Dec 01 [Epub ahead of print]

Tobias Nordström, Ola Bratt, Joakim Örtegren, Markus Aly, Jan Adolfsson, Henrik Grönberg

a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;, d Urological Cancer Research Unit, Department of Translational Medicine , Lund University , Lund , Sweden ;, d Urological Cancer Research Unit, Department of Translational Medicine , Lund University , Lund , Sweden ;, a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;, f Karolinska Institutet , Department of Clinical Science, Intervention and Technology (CLINTEC) , Stockholm , Sweden ;, a Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden ;

PubMed